Prof A. Daramola

Current Principal investigator of Roche-FMI study ‘Analysing Nigerian Breast Cancer Patients to Identify Druggable Molecular Targets’. Co-PI of a UICC-funded research on ‘Androgen Receptor Expression in Triple Negative Breast Cancer (2019-2020)’ to explore new treatment pathways for Nigerian Patients. Co-Investigator in (1) An NIH funded Breast Cancer study, MEND (2016 to date); (2) Validation of the GeneXpert® Breast Cancer STRAT4 assay for immunohistochemistry, funded by Cepheid and Stanford University (2018 to date); (3) Breast Cancer Research Foundation and University of Chicago Centre for Global Health funded Clinical trial ARETTA (2019 to date)